Report Detail
Global Over-The-Counter (OTC) Drugs Market Insights, Forecast to 2025
- RnM3234698 |
- 02 April, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
The global Over-The-Counter (OTC) Drugs market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Over-The-Counter (OTC) Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Over-The-Counter (OTC) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Over-The-Counter (OTC) Drugs in these regions.
This research report categorizes the global Over-The-Counter (OTC) Drugs market by top players/brands, region, type and end user. This report also studies the global Over-The-Counter (OTC) Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
Boehringer Ingelheim
GSK
Novartis
Pfizer
PGT healthcare
Sanofi
Teva Pharmaceuticals
Takeda
Cipla
Sun Pharmaceutical Industries
Glenmark
Innovus Pharmaceuticals
Market size by Product
Cold and Flu Products
Analgesics
Dermatological Products
Gastrointestinal Products
Vitamin
Other
Market size by End User
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Over-The-Counter (OTC) Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Over-The-Counter (OTC) Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Over-The-Counter (OTC) Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Over-The-Counter (OTC) Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Over-The-Counter (OTC) Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Over-The-Counter (OTC) Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Over-The-Counter (OTC) Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Product
- 1.4.2 Cold and Flu Products
- 1.4.3 Analgesics
- 1.4.4 Dermatological Products
- 1.4.5 Gastrointestinal Products
- 1.4.6 Vitamin
- 1.4.7 Other
- 1.5 Market by End User
- 1.5.1 Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by End User
- 1.5.2 Hospital Pharmacy
- 1.5.3 Retail Pharmacy
- 1.5.4 Online Pharmacy
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Over-The-Counter (OTC) Drugs Market Size
- 2.1.1 Global Over-The-Counter (OTC) Drugs Revenue 2014-2025
- 2.1.2 Global Over-The-Counter (OTC) Drugs Sales 2014-2025
- 2.2 Over-The-Counter (OTC) Drugs Growth Rate by Regions
- 2.2.1 Global Over-The-Counter (OTC) Drugs Sales by Regions
- 2.2.2 Global Over-The-Counter (OTC) Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Over-The-Counter (OTC) Drugs Sales by Manufacturers
- 3.1.1 Over-The-Counter (OTC) Drugs Sales by Manufacturers
- 3.1.2 Over-The-Counter (OTC) Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Over-The-Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Over-The-Counter (OTC) Drugs Revenue by Manufacturers
- 3.2.1 Over-The-Counter (OTC) Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Over-The-Counter (OTC) Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Over-The-Counter (OTC) Drugs Price by Manufacturers
- 3.4 Over-The-Counter (OTC) Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Over-The-Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Over-The-Counter (OTC) Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Over-The-Counter (OTC) Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Over-The-Counter (OTC) Drugs Sales by Product
- 4.2 Global Over-The-Counter (OTC) Drugs Revenue by Product
- 4.3 Over-The-Counter (OTC) Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Over-The-Counter (OTC) Drugs Breakdown Data by End User
6 North America
- 6.1 North America Over-The-Counter (OTC) Drugs by Countries
- 6.1.1 North America Over-The-Counter (OTC) Drugs Sales by Countries
- 6.1.2 North America Over-The-Counter (OTC) Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Over-The-Counter (OTC) Drugs by Product
- 6.3 North America Over-The-Counter (OTC) Drugs by End User
7 Europe
- 7.1 Europe Over-The-Counter (OTC) Drugs by Countries
- 7.1.1 Europe Over-The-Counter (OTC) Drugs Sales by Countries
- 7.1.2 Europe Over-The-Counter (OTC) Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Over-The-Counter (OTC) Drugs by Product
- 7.3 Europe Over-The-Counter (OTC) Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Over-The-Counter (OTC) Drugs by Countries
- 8.1.1 Asia Pacific Over-The-Counter (OTC) Drugs Sales by Countries
- 8.1.2 Asia Pacific Over-The-Counter (OTC) Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Over-The-Counter (OTC) Drugs by Product
- 8.3 Asia Pacific Over-The-Counter (OTC) Drugs by End User
9 Central & South America
- 9.1 Central & South America Over-The-Counter (OTC) Drugs by Countries
- 9.1.1 Central & South America Over-The-Counter (OTC) Drugs Sales by Countries
- 9.1.2 Central & South America Over-The-Counter (OTC) Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Over-The-Counter (OTC) Drugs by Product
- 9.3 Central & South America Over-The-Counter (OTC) Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Over-The-Counter (OTC) Drugs by Countries
- 10.1.1 Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Countries
- 10.1.2 Middle East and Africa Over-The-Counter (OTC) Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Over-The-Counter (OTC) Drugs by Product
- 10.3 Middle East and Africa Over-The-Counter (OTC) Drugs by End User
11 Company Profiles
- 11.1 Bayer
- 11.1.1 Bayer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bayer Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bayer Over-The-Counter (OTC) Drugs Products Offered
- 11.1.5 Bayer Recent Development
- 11.2 Boehringer Ingelheim
- 11.2.1 Boehringer Ingelheim Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Products Offered
- 11.2.5 Boehringer Ingelheim Recent Development
- 11.3 GSK
- 11.3.1 GSK Company Details
- 11.3.2 Company Business Overview
- 11.3.3 GSK Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 GSK Over-The-Counter (OTC) Drugs Products Offered
- 11.3.5 GSK Recent Development
- 11.4 Novartis
- 11.4.1 Novartis Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Novartis Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Novartis Over-The-Counter (OTC) Drugs Products Offered
- 11.4.5 Novartis Recent Development
- 11.5 Pfizer
- 11.5.1 Pfizer Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Pfizer Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Pfizer Over-The-Counter (OTC) Drugs Products Offered
- 11.5.5 Pfizer Recent Development
- 11.6 PGT healthcare
- 11.6.1 PGT healthcare Company Details
- 11.6.2 Company Business Overview
- 11.6.3 PGT healthcare Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 PGT healthcare Over-The-Counter (OTC) Drugs Products Offered
- 11.6.5 PGT healthcare Recent Development
- 11.7 Sanofi
- 11.7.1 Sanofi Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Sanofi Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Sanofi Over-The-Counter (OTC) Drugs Products Offered
- 11.7.5 Sanofi Recent Development
- 11.8 Teva Pharmaceuticals
- 11.8.1 Teva Pharmaceuticals Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Products Offered
- 11.8.5 Teva Pharmaceuticals Recent Development
- 11.9 Takeda
- 11.9.1 Takeda Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Takeda Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Takeda Over-The-Counter (OTC) Drugs Products Offered
- 11.9.5 Takeda Recent Development
- 11.10 Cipla
- 11.10.1 Cipla Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Cipla Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Cipla Over-The-Counter (OTC) Drugs Products Offered
- 11.10.5 Cipla Recent Development
- 11.11 Sun Pharmaceutical Industries
- 11.12 Glenmark
- 11.13 Innovus Pharmaceuticals
12 Future Forecast
- 12.1 Over-The-Counter (OTC) Drugs Market Forecast by Regions
- 12.1.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Over-The-Counter (OTC) Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Over-The-Counter (OTC) Drugs Market Forecast by Product
- 12.2.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Over-The-Counter (OTC) Drugs Revenue Forecast by Product 2019-2025
- 12.3 Over-The-Counter (OTC) Drugs Market Forecast by End User
- 12.4 North America Over-The-Counter (OTC) Drugs Forecast
- 12.5 Europe Over-The-Counter (OTC) Drugs Forecast
- 12.6 Asia Pacific Over-The-Counter (OTC) Drugs Forecast
- 12.7 Central & South America Over-The-Counter (OTC) Drugs Forecast
- 12.8 Middle East and Africa Over-The-Counter (OTC) Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Over-The-Counter (OTC) Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Over-The-Counter (OTC) Drugs. Industry analysis & Market Report on Over-The-Counter (OTC) Drugs is a syndicated market report, published as Global Over-The-Counter (OTC) Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Over-The-Counter (OTC) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
